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Purpose: To determine the safety, effectiveness, and problems encountered with endovas- 
cular repair of abdominal aortic aneurysm (AAA). Initial experience with endoluminal 
stent grafts was examined and compared with outcome for a matched concurrent con- 
trol group undergoing conventional operative repair of AAA. 
Methods: Over a 3-year period, 30 patients underwent attempts at endovascular repair of 
infrarenal AAA. Of  the 28 (93%) successfully implanted endografts, 8 were tube endo- 
grafts, 8 bifurcated grafts, and 12 aortouniiliac grafts combined with femorofemoral 
bypass. Most of the procedures were performed in the past year because the availability 
of bifurcated and aortoiliac endografts markedly expanded the percentage of patients 
with AAA who might be treated with endoluminal methods. The follow-up period 
ranged from 1 to 44 months, with a mean value of 11 months. 
Results: Endovascular procedures demonstrated significant advantages with respect o 
reduced blood loss (408 versus 1287 ml), use of an intensive care unit (0.1 versus 1.75 
days), length of hospitalization (3.9 versus 10.3 days), and quicker ecovery (11 versus 
47 days). Although the total number of postoperative complications was identical for 
the two groups, the nature of the complications differed considerably. Local and vascu- 
lar complications characteristic of endovascular repair could frequently be corrected at 
the time of the procedure and tended to be less severe than systemic or remote compli- 
cations, which predominated among the open surgical repair group. On an intent-to- 
treat basis, 23 (77%) of the 30 AAAs were successfully managed with endoluminal repair. 
The seven (23%) failures were attributable to two immediate conversions caused by 
access problems, three persistent endoleaks, one late conversion caused by AAA expan- 
sion, and one late rupture. 
Conclusions: Although less definitive than those for conventional operations, these early 
results suggest hat endovascular AAA repair offers considerable benefits for appropri- 
ate patients. The results justify continued application of this method of AAA repair, par- 
ticularly in the treatment of older persons at high risk. (J Vasc Surg 1998;27:992-1005.) 
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The possibility of  repair of  abdominal aortic 
aneurysm (AAA) by means of  placement of  a pros- 
thetic graft inserted from a remote site, guided to 
the desired location intraluminally under radio- 
logic control ,  and secured with an expandable 
stent attachment system to exclude the AAA has 
been demonstrated in several early reports after 
the initial successful application of the method by 
Parodi et al. in 1991.1-6 A growing number  of  
studies detai l ing experience with a variety of  
transluminally placed endovascular graft (TPEG) 
devices have been published to document the effi- 
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Table I. Anatomic selection criteria for endovascular repair of abdominal aortic aneurysm 
Cr#erion Specification 
Proximal aneurysm neck 
Distal attachment site 
Tube endograft 
Bifurcated graft 
Aor totmiiliac 
Proximal aortic neck angulation 
lilac artery 
Other factors 
_>1.5 cm long, _<26 mm in diameter 
Distal aortic cuff->1.5 cm long, -<26 mm in diameter 
Distal common iliac ->1.5 cm long, <14 mm in diameter 
Ipsilateral common or external lilac _<14 mm in diameter with AAA 
morphology that allowed preservation of at least one internal iliac 
artery 
<75 degrees 
>7-8 mm diameter without excessive tortuosity or calcification 
No significant accessory renal artery or "critical" inferior mesenteric 
artery arising from AAA sac 
AAA, Abdominal aortic aneurysm. 
cacy and generally satisfactory early results of 
endovascular AAA repair. 7q6 
Although the prospects of lower morbidity and 
mortality rates, possible cost savings, and quicker 
patient recovery hold tremendous appeal for this less 
invasive method of treatment, much uncertainty 
continues to exist about its proper application in the 
treatment of patients with AAA and its success and 
reliability compared with conventional open opera- 
tive repair. To examine some of these issues and 
determine the safety, early effectiveness, and prob- 
lems encountered with endoluminal repair, initial 
experience at a large tertiary center with develop- 
ment of a program of endovascular AAA repair was 
reviewed and outcome measures compared with 
those for a similar concurrent control group under- 
going conventional surgical repair. 
METHODS 
From January 1994 through May 1997, a total 
of 36 patients underwent TPEG repair of aneurys- 
real disease. Six endoluminal stent grafts for tho- 
racic, iliac, or other unusual or complex aneurysms 
were successfully deployed but not considered fur- 
ther in the analysis. This left 30 patients undergoing 
attempts at endovascular management of elective 
infrarenal AAA. 
Patients were selected as possible candidates for 
endovascular repair on the basis of various anatomic 
criteria with respect to the aneurysm and adjacent ves- 
sels. Selection criteria are outlined in Table I. These 
anatomic features were evaluated with a combination 
of preprocedural imaging techniques. All patients 
underwent contrast-enhanced spiral computed 
tomography (CT) with 3.0 mm cuts and three- 
dimensional vascular econstruction. If initial mea- 
surements and morphologic haracteristics of the 
AAA appeared favorable for possible endovascular 
repair, contrast-enhanced multiplanar angiography 
was performed with a special catheter with radiopaque 
markers at 1 cm intervals (Cook, Bloomington, Ind.) 
to allow correction for magnification and precise 
length and diameter measurements. 
Anatomic measurements a d other morphologic 
features derived from the combination of imaging 
studies included distance between the lowest renal 
artery and the AAA (length of proximal neck), dis- 
tance between the end of the AAA and aortic bifur- 
cation, if any (length of distal neck), overall engths 
between the renal arteries and both the aortic and 
iliac bifurcations, diameter and configuration of the 
proximal and distal necks, and length and diameter 
of the common and external i iac arteries. Degree of 
angulation of the proximal neck, tortuosity of the 
iliac vessels, and extent of calcification and mural 
thrombus in all locations also were determined. The 
angiogram also provided important information 
regarding patency and potential importance of the 
inferior mesenteric artery in terms of colonic perfu- 
sion and helped with identification of any aberrant 
anatomic features of the renal artery. If anatomic 
delineation suggested that endovascular AAA repair 
would be feasible, the options of open and endolu- 
minal repair were discussed with the patient. If thc 
patient chose to proceed with endovascular repair, 
informed consent was obtained from all participants 
after the technique, risks, and possible complications 
of both forms of treatment had been discussed in 
detail. The protocol for endovascular AAA repair 
was approved by the institutional review board of 
Massachusetts General Hospital. 
Of the 30 patients for whom endovascular AAA 
repair was attempted, two patients (7%) needed con- 
version to open surgical repair because small, dis- 
eased iliac arteries precluded satisfactory access to 
the aneurysm for endovascular graft deployment 
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despite prolonged efforts from both sides. Of the 28 
(93%) successfully implanted endografts, 25 were 
EVT devices (EndoVascular Technologies, Menlo 
Park, Calif.) used as part of United States Food and 
Drug Administration-approved phase I and II mul- 
tiinstitutional trials of EVT devices. The EVT device 
and method of insertion have been well described by 
Moore and Rutherford for the EVT investigators.10 
Three endografts were custom-made vices we fab- 
ricated from available stent (Gianturco Z-shaped 
self-expanding stents; Cook) and vascular prosthetic 
graft materials, as described by Dake ctal. 17 The 
custom-made endografts were used when the mor- 
phologic features of the aneurysm were notsuitable 
for the EVT devices according to the protocol crite- 
ria as outlined in Table I. In one of these patients, 
the AAA neck exceeded 26 mm in maximal diame- 
ter. In the other two complex iliac aneurysmal dis- 
ease necessitated use of an aortouniiliac onfigura- 
tion with occlusion of the contralateral iliac artery. 
The custom-made devices were inserted through a 
Keller-Timmermans introducer set with a Rutner 
adapter (Cook) and deployed with a pusher rod as 
described by Dal(e et al.17 
Endograft configurations included eight tube, 
eight bifurcated, and 12 aortotmiiliac grafts combined 
with contralateral iliac occlusion and femorofemoral 
bypass. With the aortouniiliac graft method of 
endovascular AAA repair, occlusion of the contralat- 
eral common iliac artery was achieved by means of 
transcatheter insertion of multiple coils or translumi- 
nal deployment of a special occluding covered stent 
(Endosoc; EndoVascular Technologies). Standard 
Dacron polyester or polytetrafiuoroethylene (PTFE) 
vascular grafts were used for the femorofemoral 
bypasses. A transfemoral pproach through limited 
groin incisions was used to treat 26 patients. A limit- 
ed retroperitoneal pproach allowed insertion of the 
cndograft through an iliac artery graft conduit anas- 
tomosed end to side to the common iliac artery in the 
treatment of two patients with small, diseased external 
iliac artery segments, a  previously described by May 
et al.4 
All procedures were performed by a team con- 
sisting of vascular surgeons and interventional radi- 
ologists, and all were performed in an operating 
room under general anesthesia. All patients were 
judged to be acceptable candidates for conventional 
open operation if endoluminal repair was not feasi- 
ble. Intraoperative radiologic imaging was per- 
formed with a high-quality portable G-arm fluoro- 
scopic device with digital imaging and road-map- 
ping capability on a special radiolucent operating 
table with movable top compatible with use of the 
imaging system. Most of the procedures were per- 
formed in the last year of the study, when develop- 
ment and availability of both bifurcated and aor- 
touniiliac endografts enabled approximately 50% of 
patients with AAA to be candidates for endovascular 
repair as opposed to less than 10% of patients when 
only a tube endograft was available in the initial 
interval of the study period. 
Initial assessment of endograft function and ver- 
ification of satisfactory exclusion of the AAA were 
evaluated by means of intraoperative postdeploy- 
ment angiography and predischarge contrast- 
enhanced CT, both with delayed filming, to deter- 
mine whether any contrast enhancement of the 
aneurysmal sac was present. Plain abdominal radi- 
ographs to identify the position of  the attachment 
devices and longitudinal radiopaque graft markers 
were obtained, as were color flow duplex scans of 
the abdomen to assess flow through the endograft 
and confirm absence of flow within the AAA itsel£ 
CT, plain abdominal radiography, and physical 
examinations including pulse evaluation and ankle- 
brachial index measurements were repeated 6 
months and 1 year after the procedure and annually 
thereafter. 
Outcome parameters evaluated for endovascular 
repair included operative time, blood loss, use of an 
intensive care unit, length of hospital stay, death, 
and both local or vascular and systemic or remote 
complications of the procedure, as suggested by the 
Ad Hoc Committee for Standardized Reporting 
Practices in Vascular Surgery of the Society for 
Vascular Surgery and International Society for 
Cardiovascular Surgery. 18 Time from hospital dis- 
charge to return of a feeling of preoperative well- 
being was determined by means of a retrospective 
questionnaire completed by all patients at the time 
of initial follow-up visit. The follow-up period after 
endovascular repair ranged from 1 to 44 months 
with a mean follow-up time of 11 months. 
These early results of endovascular AAA repair 
were compared with those of similar outcome assess- 
ment for a concurrent cohort of 28 patients of sim- 
ilar age, sex, risk factor status, AAA size, and 
aneurysm extent and morphologic features who 
underwent conventional open operative repair dur- 
ing the same time.18j9 Mean AAA size (5.52 cm 
open, 5.50 cm endovascular) and size ranges (4.5 to 
8.9 cm open, 4.2 to 8.5 cm endovascular) were 
nearly identical. Six of these surgical control patients 
were participants in the first phase of the random- 
ized EVT device protocol who were assigned to the 
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Table II. Demographic and clinical characteristics of patients in each group 
Characteristic Open repair (n = 28) Endovascular repair (n = 28) p Value 
Mean age (yr) 73.9 75.8 NS 
Sex (M/F) 20/8  24/4  NS 
Maximum diameter of abdominal aortic 5.52 5.50 NS 
aneurysm (cm; mean value) 
Current tobacco use 5 (18) 3 (11) NS 
Hypertension 13 (46) 16 (57) NS 
Diabetes mellitus 2 (7) 3 (11) NS 
Hyperlipidemia 8 (29) 9 (32) NS 
Cardiac disease 15 (54) 17 (61) NS 
Cerebrovascular disease 4 (14) 5 (18) NS 
Pulmonary disease 8 (29) 12 (43) NS 
Creatinine >1.7 mg/di 3 (11) 4 (14) NS 
Peripheral vascular disease 6 (21 ) 5 ( 18 ) NS 
Unless indicated otherwise, values are number of patients with percentages in parentheses. 
NS, not significant. 
surgical repair group. When the EVT device study 
design was altered to become anonrandomized pro- 
tocol, control patients were selected from patients 
with AAAs anatomically suitable for either form of 
treatment but who preferred conventional operative 
repair to endoluminal grafting because of its proved 
track record in contrast to the more uncertain results 
of TPEG repair. 
Patients undergoing nonelective surgical repair 
because of symptomatic aneurysms or with anatomy 
unfavorable to endoluminal repair that would make 
the procedure more challenging and candidates with 
adverse circumstances for open surgical repair were 
specifically excluded. In the control group, 50% of 
patients underwent tube graft repair, and 50% were 
treated with bifurcated grafts. Surgical rcpair was 
performed through a transperitoneal route for 24 
patients and a retroperitoneal flank approach for 
four patients. As shown in Table II, patients under- 
going open surgical repair and those undergoing 
endovascular repair were well matched without sig- 
nificant differences in any parameter. 
Comparisons between the two groups were per- 
formed with two-sample t tests (with equal or  
unequal variances assumption) for continuous vari- 
ables or Fisher exact tests for discrete variables. All 
statistical analyses were conducted with SAS soft- 
ware (SAS Institute, Cary, N.C.). A two-tailed p 
value less than 0.05 was considered statistically sig- 
nificant. 
RESULTS 
A comparison of outcome parameters for the two 
groups is shown in Table III. Mean operative time 
for endovascular repair was approximately one-half 
hour longer than that of conventional open repair, 
although this difference was not statistically signifi- 
cant. As would be anticipated, tube endografts took 
the shortest time (mean value 181 minutes) and aor- 
touniiliac TPEG, with the concomitant need to 
occlude the contralateral iliac artery and construct a
femorofemoral bypass to revascniarize the contralat- 
eral limb, took the longest ime to perform (mean 
value 230 minutes). Endovascular repairs were pro- 
longed to some extent by the need for retroperi- 
toneal access for endograft insertion for two 
patients, concomitant femoral artery aneurysm 
repair by means of a segmental interposition graft at 
the insertion site for two patients, and the occasion- 
al need to repair damaged arterial access ites. 
There wcrc no periopcrative deaths in either 
group, and no late deaths occurred during the fol- 
low-up period to the date of this report. Compared 
with conventional repair, endoluminal grafting 
demonstrated substantial advantages withrespect o 
reduced blood loss, use of an intensive care unit, 
length of hospital stay, rate of postoperative systemic 
or remote complications, and time to return of a 
feeling of preprocedural state of health (Table III). 
These benefits were somewhat offset by the signifi- 
cantly higher incidence of perioperative local or vas- 
cular complications among patients undergoing 
endovascular repair. Overall, the total number of 
postoperative complications was identical between 
the two groups. In terms of the number of patients 
experiencing any problems, 54% of patients under- 
going endovascular repair were free of complica- 
tions, and 50% of those undergoing open repair sus- 
tained no perioperative complications. 
Complications. Perioperative complications 
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Table I I I .  Comparison of outcome parameters 
Parameter Open repair (n = 28) Endovascular repair (n = 28) p Value 
Operative time (hr) 3.25 3.52 NS 
Blood loss (ml) 1287 498 <0.01 
Intensive care unit stay (d) 1.75 0.I 0.008 
Hospital stay (d) 10.3 3.9 0.0001 
No. of deaths 0 0 NS 
Total no. of complications 20 20 NS 
No. of local or vascular complications 2 16 <0.001 
No. of systemic or remote complications 18 4 <0.00I 
Recovery time (d) 47 11 0.0001 
All parameters are mean values. 
Table IV. Complications of  open surgical repair 
2,70. 
Complication of patients 
Local or vascular 2 
Abdominal wound dehiscence 1 
Subcutaneous wound separation 1 
Systemic or remote 18 
Cardiac (2 myocardial nfarction, 2 congestive 6 
heart failure, 2 arrhythmia) 
Pulmonary (3 pneumonia, 1 respiratory failure) 4 
Gastrointestinal (2 prolonged ileus, 1 Clostridium 3 
difficile colitis) 
Renal (1 transient acute tubular necrosis, 2 
1 urinary sepsis) 
Neurologic (1 stroke, 1 seizure, 1encephalopathy) 3 
Table V. Complications of endovascular repair 
Complication No. of patients 
Local or vascular 16 
Groin wound problem 4 
Arterial injury 2 
Limb ischemia 4 
Persistent endoleak 3 
Minor thromboemboli 1 
Late conversion toopen repair 1 
Late rupture leading to conversion 1 
Systemic or remote 4 
Subendocardial myocardial nfarction 1 
Transient arrhythmia 1 
Mild congestive h art failure 1 
Pulmonary infiltrate 1 
among the two groups are listed in Tables IV and V. 
Although there was no difference in overall inci- 
dence of complications, the nature of  the problems 
differed considerably between the two groups. Many 
of  the local or vascular problems that predominated 
after endovascular repair could be readily corrected 
by means of  immediate reintervention or utpatient 
care, whereas a large port ion of  the systemic or 
remote postoperative problems in the surgical 
cohort tended to be more serious and often led to 
need for continuing hospitalization, as reflected in 
the marked difference in length of stay between the 
two groups. For example, two patients who under- 
went endovascular repair sustained arterial damage 
to the femoral artery at the insertion site. The dam- 
age necessitated local endarterectomy and patch 
repair for one patient and a segmental distal external 
iliac to femoral interposition graft for another 
patient. Both problems were adily corrected at the 
time of the procedure and did not lead to any seque- 
lae. There were no instances of  arterial perforation 
during passage of the endovascular devices through 
the iliofemoral system or aneurysm during position- 
ing for endograft deployment. 
A similar type of local or vascular complication 
that occurred much more commonly after endovas- 
cular repair is illustrated by three patients who had 
symptoms of  flow obstruction and limb ischemia 2 
to 6 hours after endograft placement. Immediate 
groin reexploration under local anesthesia nd 
repeat angiography demonstrated no thrombus but 
rather kinking of the unsupported graft limb in tor- 
tuous or angulated native segments of iliac artery. 
The problems had not been evident when the pro- 
cedures were completed. The angiographic appear- 
ance of  the endograft had been satisfactory, good 
distal perfusion had been assessed at pulse examina- 
tion, and pulse volume recordings and Doppler 
pressure measurements were good. We presume that 
apparent shifting of position of the endoprosthcses 
within the native arterial segments occurred in the 
early hours after implantation. This was readily cor- 
rected in each instance by means of deployment of a 
Wallstent device in the narrowed port ion of  the 
endograft (Fig. 1). There were no further problems 
nor was length of  stay prolonged. The final case of 
limb flow obstruction with limb ischemia was that of 
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Fig. 1. Example of endograft limb kinldng. A, Preoperative angiogram shows angulation of 
left common iliac artery. B~ Intraprocedural ngiogram demonstrates kinking of cndograft 
limb within angulated native art rial segment. C, Correction of compromised flow with inser- 
tion of Wallstent device. D, Postprocedural CT scan reveals widely patent left stented endo- 
graft limb within excluded abdominal aortic aneurysmal sac. 
a patient with thrombosis of one limb of  an EVT 
bifurcated endograft 7 weeks after discharge. Clot 
lysis was readily achieved with a short course of  
urokinase therapy. Repeated radiographs demon- 
strated a similar endograft limb ldnk in a tortuous 
native iliac arterial segment. This kink was corrected 
with a Wallstent device. Graft limb patency was well 
maintained thereafter. 
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Fig. 2. A, Discharge CT scan shows endoleak with crescent-shaped accumulation of c trast 
material outside confines of endograft lumen but within sac of abdominal ortic aneurysm. B, 
Follow-up CT scan 6 weeks after discharge demonstrates spontaneous sealing of endoleak and 
no contrast enhancement of AAA sac. 
Groin wound healing problems were fairly com- 
mon after endovascular repair, presumably because 
of the time these access ites were open and the mul- 
tiple manipulations performed through them. The 
problems usually were minor but were judged clini- 
cally significant for four patients. Outpatient man- 
agement was possible for three of these patients, but 
one patient needed readmission for local dressings 
and antibiotic therapy. None of these wound prob- 
lems led to graft exposure or infection. 
One patient who underwent endovascular repair 
had a small discolored area of one toe tip 2 days after 
the procedure, presumably representing a small 
thromboembolic event. This event was self-limited 
and not of clinical importance. No patient had seri- 
ous thromboembolic complications. No deteriora- 
tion of renal function occurred among any patient 
undergoing endovascular repair, either from contrast 
agent-induced ysfunction, embolic debris, or 
obstruction of renal arterial flow caused by malposi- 
tioning of the endoprosthesis. The average volume 
of contrast agent administered uring endograft 
insertion was 145 ml of dilute medium, a smaller 
volume and reduced iodine load than a convention- 
al diagnostic angiogram or CT scan. No signs or 
symptoms uggestive of colonic ischemia occurred 
among patients in the study group, although such a 
complication of endovascular repair has been report- 
ed 14 and one patient reated by our group recently 
and not included in the study series had clinical signs 
and colonoscopic evidence of colonic ischemia fter 
cndograft coverage of a patent inferior mescntcric 
artery. Fortunately this problem could be managed 
nonoperatively with intestinal rest and antibiotic 
therapy. 
Endoleaks. A potentially important complica- 
tion among patients undergoing endovascular repair 
is failure to totally exclude the AAA from the arterial 
system. Persistent contrast enhancement of the AAA 
sac at postdeployment angiography or contrast CT 
scan has been called endoleak by White et al. 2° Such 
endoleaks were detected at the time of discharge 
among six (21%) patients. For five of these six 
patients, it was our judgment hat such contrast 
enhancement represented continued perfusion of the 
AAA sac by patent branch arteries uch as the inferi- 
or mesenteric artcry or lumbar artcrics (branch-to- 
branch flow) rather than leak of contrast matcrial at 
either the proximal or distal attachment si es. On fol- 
low-up CT scans, three of these six endoleaks had 
disappeared, presumably representing spontaneous 
scaling (Fig. 2). However, onc cndolcak that had 
sealed spontaneously at 6 wccks was demonstrated 
on the 1-year follow-up scan. This patient and two 
other patients with persistent endoleaks have under- 
gone observation for as long as 1 year after endograft 
placement without development of symptoms or any 
expansion of AAA size on follow-up CT scans. One 
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Fig. 3. Serial plain abdominal radiographs suggest probable migration of distal attachment 
system in patient with AAA rupture 2.5 years after endoluminal repair. A, Six-month radi- 
ograph. B, Two-year radiograph. Two strut fractures are present in the distal attachment frame 
(small arrows) and the attachment system is higher elative to calcified plaque in the distal AAA 
wall (large arrow). C, Two and one-half year adiograph 2 weeks before rupture. Attachment 
system appears further separated from fractured hooks and area of calcification. No contrast 
leak was evident on CT scan. 
patient with a large persistent proximal eak around 
the attachment system, which occurred after endo- 
graft repair of an AAA with a very angulated and 
technically challenging proximal neck, had acute 
back pain within 4 weeks of his procedure and had 
CT evidence of aneurysm expansion without rup- 
ture. He underwent urgent surgical conversion and 
did well. 
Late rupture.  One patient who underwent 
apparently successful endovascular repair who had 
late rupture of the aneurysm merits more detailed 
description. A tube endograft repair was performed 
early in the series, October 1994. The patient did 
well during the ensuing 2 ½ years with no endoleak 
evident on five follow-up CT scans. The AAA had 
been documented to diminish in size from 5.0 cm at 
the time of repair to 3.6 cm in maximal diameter at 
the 2 ~A year CT scan. Two weeks later, however, he 
had sudden back and abdominal pain. Emergency 
abdominal CT at a local hospital suggested a 5 cm 
AAA with a retroperitoneal hematoma. The patient 
was transferred to Massachusetts General Hospital 
and underwent emergency surgical repair. At opera- 
tion, the distal endograft attachment system was 
found floating freely in the AAA sac. The proximal 
attachment system was juxtarenal and securely fixed. 
Supraceliac clamping allowed suturing of a standard 
Dacron graft to the proximal body of the prior endo- 
graft, which was then anastomosed to the aortic 
bifurcation to make a composite endovascular-con- 
ventional prosthetic tube repair. The patient recov- 
ered satisfactorily. 
In retrospect, careful review of the patient's eri- 
al plain abdominal follow-up radiographs suggested 
likely migration of the distal attachment system (Fig. 
3). Although no endoleak was evident on multiple 
CT scans, we believe this was likely a harbinger of 
insecure distal endograft attachment despite the 
absence of cndoleak and speculate that the sudden 
appearance of a late endoleak reperfused an atretic 
AAA sac and led to immediate rupture. This was the 
only instance of endograft device migration in the 
series. The importance of plain radiographs in fol- 
low-up care after insertion of an endograft device 
was emphasized in the report of May ctal., 21 who 
described a fairly similar situation. 
Change in aneurysm size. In a small group of 
patients undergoing endovascular repair with ade- 
quate follow-up intervals of 1 year or more, there 
was a mean 1 cm decrease in AAA size. Aneurysm 
size remained unchanged among the other patients, 
even the three patients with persistent endoleak. 
Other patients without changes in aneurysm size 
were early in their follow-up periods. 
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DISCUSSION 
Conventional operative repair of AAA, with the 
goal of preventing aneurysm rupture and perhaps 
prolonging patient survival, is well documented as a 
very effective and durable method of treatment that 
can be performed with highly acceptable morbidity 
and mortality rates at many experienced centers. 22-25 
Nonethelcss, the risk of operation may be consider- 
ably higher (as high as 10%) in community-based 
reports, 26 and patients at high risk often are denied 
surgical repair because of presumed hazards of the 
procedure. In addition, conventional repair repre- 
sents a considerable xpense and drain on hospital 
resources, and convalescence ommonly requires a 
prolonged period of many months. The possibility 
that a less invasive method of treatment might reduce 
risks and achieve cost savings and other patient ben- 
efits has tremendous appeal to patients and physicians 
alike and has generated considerable enthusiasm in 
the development and use of such devices. 
Our data, and that from multiple other reports 
within the past few years, support he concept hat 
many properly selected patients with AAA can be 
successfully treated with endoluminal repair, at least 
in the short- to midterm time frame. The primary 
determinants of feasibility of endovascular AAA 
repair are, and will likely continue to be, anatomic 
features as outlined in Table I. It is not entirely clear 
what percentage of patients it may be possible to 
treat successfully with endoluminal methods, but sev- 
eral authors have estimated from anatomic studies 
that between 30% and 60% of patients with AAA have 
suitable AAA morphologic features for TPEG repair 
with currently available devices.15,16, 27-29In our ini- 
tial experience, ndoluminal repair was possible for 
less than 10% of patients when only a tube endograft 
was available, but possible use increased to approxi- 
mately 50% of patients with aneurysms as bifurcation 
and tapered aortouniiliac endografts became avail- 
able. The expanded potential use of endovascular 
repair is reflected by the fact that an additional 21 
patients with AAA have been treated with endovas- 
cular stent grafts by our group in the past 5 months 
alone between the end of the study period and prepa- 
ration of this report. This brings our total experience 
to treatment of 57 patients in this way with ongoing 
results of endoluminal repair similar to those of the 
initial experience detailed herein. 
Aortouniiliac endografts offer perhaps the great- 
est anatomic flexibility.4,7,8,14 Further development 
of modular cndografts that allow individualization f 
each device to meet the wide variety of aortoiliac 
anatomy and corresponding wide range of length 
and diameter requirements among individual 
patients may increase potential use of endovascular 
repair. 30 Because of somewhat complex patterns of 
aneurysmal involvement of differing extent in both 
iliac arteries in many patients, aortouniiliac ndo- 
grafts were the most common endograft configura- 
tion in our series. Their utility and the fact that they 
provide the maximum anatomic flexibility and 
widest potential application of the method of 
endovascular repair of AAA have been described in 
several other series.4,7,8,14 Although no modular or 
component endografts were used in our early expe- 
rience, it seems clear that further development of 
modular devices that enable use of iliac limbs of dif- 
fering lengths and calibers will allow greater individ- 
ualization of each device, better ability to meet the 
wide variety of anatomic requirements of potential 
patients, and likely application ofendovascular repair 
to an even higher percentage of patients with 
AAA.S0 
An even higher percentage of AAA patients with 
complex anatomy and extensive aneurysmal disease 
involving both common iliac arteries may be treated 
with endoluminal techniques if one is willing to 
exclude both internal ilac arteries. Most groups cur- 
renfly performing endohiminal repair of AAA have 
avoided this step because of potential consequences 
of pelvic and colonic ischemia. Marin et al.,7,31 how- 
ever, showed that this step often may be tal~en with- 
out serious clinical consequences and can certainly 
increase potential application of TPEG management. 
According to an intent-to-treat nalysis, our data 
indicate that it was possible to treat successfully 23 
(77%) of 30 patients by means of endoluminal 
methods. Included within this clinical success group 
are four patients with obstruction of lower extremi- 
ty blood flow who needed additional endovascular 
interventions. The seven (23%) patients with results 
judged clinical failures include the two patients who 
needed immediate conversion to surgical repair 
because of the iliac arteries presented access prob- 
lems, the two patients who needed late conversion 
to open repair (one symptomatic expanding AAA, 
one late rupture), and three patients with persistent 
endoleal¢, even though no symptoms of AAA or size 
increase occurred. This clinical success rate is within 
the 75% to 85% range of initial success reported by 
many groups.8,1°,15,16,32 When persistent endoleaks 
or other technical complications have been 
addressed with interventional methods uch as addi- 
tional stent grafts and coil embolization of leak sites, 
secondary success rates as high as 97% have been 
described for endoluminal repair, is 
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Our results appear to validate the anticipated 
potential benefits of successful endovascular man- 
agement of AAA. Particularly impressive was the 
marked reduction in mean values for use of an inten- 
sive care unit (0.1 versus 1.75 days) and hospital 
length of stay (3.9 versus 10.3 days) and the much 
more rapid recovery time (11 versus 47 days) after 
endovascular repair. These parameters are all reflec- 
tive of the significantly lower rate of systemic or 
remote complications among patients treated with 
the less invasive method. Although the mean hospi- 
tal length of stay for patients who underwent open 
surgical repair may seem excessive, this was adverse- 
ly influenced by the prolonged stays of  several 
patients with particularly severe postoperative sys- 
temic complications. Length of stay for the surgical 
group ranged from 4 to 44 days. Even with elimina- 
tion of an outlier with length of stay of 44 days due 
to postoperative r spiratory failure, tracheostomy, 
and prolonged mechanical ventilatory support, 
mean length of stay was 9.1 days. Such data are in 
accord with other reported experiences, even in con- 
temporary practice. For example, Muluk et al. 33 
found that use of clinical care pathways and case 
managers at the University of Pittsburgh helped 
reduce hospital ength of stay for surgical repair of 
AAA from 13.8 to 10.2 days, a hospital stay almost 
identical to that for our cohort who underwent 
open surgical repair. 
Although the local or vascular variety of peripro- 
cedural complications is relatively high after TPEG 
repair, as noted in series besides ours, 32 such prob- 
lems often are not as serious as those with open sur- 
gical repair. We believe such complications will likely 
continue to diminish as further technologic advances 
in endoluminal graft devices occur, as they inevitably 
will. For example, smaller caliber and more flexible 
delivery systems will help offset problems in access 
and reduce potential arterial damage during inser- 
tion. Endograft design likely will shift toward devices 
with an entire endoskeleton of stent support 
throughout the prosthesis, which will help reduce 
many of the limb blood flow problems caused by 
kinking of unsupported endografts that we found in 
this initial experience. Similar observations regarding 
need for stenting unsupported endograft limbs that 
are prone to kinking and obstruction were made by 
Chuter et al.ll Although we did not use it, intraop- 
erative intravascular ultrasonography might help in 
recognition and correction of  technical problems 
related to kinking or twisting of endograft limbs. 
The decrease in AAA size documented among 
our patients with adequate follow-up intervals up- 
ports the clinical success of endoluminal grafting. 
Other reports demonstrated that successful AAA 
exclusion with TPEG repair esults in marked reduc- 
tion of arterial pressure in the AAA sac 34-36 and a 
marked decrease in size of the ancurysm on follow- 
up CT  scans.15,16, 37-39 Conversely, prior studies 
clearly showed that persistent endoleaks are correlat- 
ed with further AAA expansion and possibly rup- 
ture.ll,37,39, 40Indeed, failure to totally exclude the 
AAA sac from arterial perfusion appears to be one of 
the principal shortcomings of endoluminal repair in 
experience reported by all investigators to date; the 
reported incidence of early endoleak ranges from 
10% to 44%.8-11,15,16,32, 41 Our 21% incidence of 
endoleak at initial discharge falls in the middle of this 
range. Although as many as 50% of these early 
endoleaks may seal spontaneously weeks to months 
after endograft implantation, 10 some of these appar- 
ently self-correcting leaks may recur later as seen in 
our series and others. In our experience, most 
endoleaks were of the branch-to-branch variety 
caused by backbleeding into the sac from the inferi- 
or mesenteric artery or lumbar vessels. Although it 
seems intuitively logical that such leaks would likely 
perfuse the AAA sac at lower pressures than perigraft 
leaks occurring at the proximal or distal attachment 
sites and thus be less likely to cause AAA expansion 
or possible rupture, this phenomenon has not been 
documented. Surgical experience with exclusion and 
bypass procedures for popliteal aneurysms or AAA 
suggests that subsequent aneurysm expansion 
caused by persistent flow in the excluded sac is quite 
unusual, although scattered cases of late expansion 
and even rupture have been described. 42-44 It is our 
bias often to place multiple endoluminal coils with- 
in the AAA sac at thc time of endovascular repair to 
promote intrasacular thrombus and potentially 
reduce the incidence of persistent endoleak caused 
by branch flow. Further study is needed to see 
whether this proves a useful adjunct. I  seems fair to 
conclude that the ultimate fate of many endoleaks 
remains unknown. Reported experience with the 
EVT device shows that persistent endoleaks often 
may continue to be observed without AAA enlarge- 
ment or other clinical consequences up to 27 
months after endovascular repair. 10 However, until 
more data and experience are available, persistent 
endoleaks should be regarded as potentially harmful 
and a failure of endoluminal treatment. 
Large endoleaks at either proximal or distal 
attachment sites appear to be harbingers of poor 
outcome and likely warrant fairly aggressive reinter- 
vention.32, 41Such a leak led to the need for urgent 
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conversion 4 weeks after endograft treatment of one 
of our patients. In some of these situations, success- 
fu! correction may be achieved with endoluminal 
reintervention rather than open conversion.15,32, 41 
We believe all TPEG procedures are best per- 
formed in an operating room. This belief is based 
not so much on the possible need for conversion to 
open repair, which is quite infrequent among prop- 
erly selected patients, but on the fairly common 
requirement for adjunctive vascular surgical proce- 
dures such as repair of  damaged access vessels or 
construction of  a femorofemoral bypass in aortouni- 
iliac endograft implantation, our most common pro- 
cedure. These procedures are best performed inthe 
sterile, well-equipped, and appropriately staffed 
environment of  an operating room. Although the 
question of who should perform these procedures 
remains quite controversial, our perception is that 
optimal results are best achieved by a team who 
combines the individual skills and knowledge of  
both vascular surgeons and interventional radiolo- 
gists. Treatment is coordinated by one person famil- 
iar with vascular disease, its natural history, and all 
management options.19, 45 
On an intent-to-treat basis, our clinical success 
rate of  77% and similar data from multiple other 
reports of  endoluminal repair suggest that this 
method of treatment is not currently as definitive as 
conventional open operation. However, early results 
are acceptable, and other benefits of the less-invasive 
approach are impressive and appealing. The possibil- 
ity of conventional operative repair is not necessarily 
precluded, although it may clearly be more difficult 
or complex if prior endovascular grafting has been 
performed. These conclusions are reflected in the 
report by May et al. 46 of a large 4-year experience 
with TPEG repair. Their data demonstrate hat con- 
ventional operation remains the most reliable 
method of AAA repair. However, the safety ofendo-  
luminal management was emphasized with the 
equivalent mortality and complication rates among 
their two groups even though 44% of patients who 
underwent endovascular repair had been rejected as 
unfit for open repair. 46 
We believe these data and the benefits docu- 
mented in our experience support continued use of 
endovascular repair, particularly in the treatment of  
older patients at high risk. As technologic advances 
occur and endoluminal treatment evolves, and if 
future studies document acceptable durability of the 
method, we believe the demonstrated benefits of  
endovascular repair will justify its use in the care of 
most patients with appropriate anatomic features. 
We gratefully acknowledge the assistance of YuChiao 
Chang, PhD, Medical Practices Evaluation Center, 
Massachusetts General Hospital, in statistical analysis, and 
Karen R. Barbarisi n manuscript reparation. 
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DISCUSSION 
Dr. Robert M. Zwolak (Lebanon, N.H.). This was a 
superb presentation on a most timely clinical issue that 
affects vascular surgery today, It is a brand new world. 
Terms like "drop zone" and "full deployment" have left 
their rightfial home in the pages of a Tom Clancy novel to 
land in the vascular operating suite. Dr. Brewster has 
shown that 50% of aortic aneurysms may now be treated 
endovascularly relying on an ever-expanding array of tube 
grafts, bifurcated grafts, component grafts, and increasing- 
ly intelligent guide wires. The overall short-term results in 
both groups are excellent. There were no deaths in 60 
patients, a minimal blood loss, and short hospital stays. 
This reflects state-of-the-art vascular surgery. However, 
there are still more questions than answers, and I would 
like to pose a few of these to Dr. Brewster. 
Postoperative kinking of graft limbs in three patients 
must have been a frustrating problem because the patients 
left the operating room with normal distal pulses. Have 
the technical issues surrounding that problem been 
resolved? Why should the grafts reposition themselves so 
much as to thrombose an iliac limb? On the basis of less 
than perfect patency of femorofemoral crossover grafts, 
the combination of the aortouniiliae graft in addition to a 
femorofemoral crossover graft remains uninspiring to me. 
What kind of patient deserves this procedure instead of an 
open aortic reconstruction? What about these endoleaks? 
Three of 28 patients (11%) who were snccessfixlly engraft- 
ed had persistent endoleaks. Those few patients with per- 
sistent endoleaks comprise our most frustrating subset at 
Dartmouth. A patient of Dr. Brewster's cohort had an 
endoleak and experienced aneurysm expansion that 
required semiurgent operative repair. Have you decided 
on a therapeutic algorithm regarding when to intervene 
on these patients with endoleaks? 
Your manuscript also speaks of a tendency to place 
multiple endoluminal coils within the aneurysm sac at the 
time of endovascular repair to promote intravascnlar 
thrombus and potentially reduce the incidence of persistent 
endoleak. I am not familiar with this. Can you tell exactly 
how you accomplished that and whether you have evidence 
that it is doing what you had hoped? What about cost con- 
siderations? Saving a day in an intensive care unit and 
almost a week in the hospital may represent a cash savings 
in excess of $10,000 per patient. However, the devices are 
vastly more expensive than the traditional aortic prosthesis, 
and the savings will dwindle if some or perhaps even all of 
the patients need to be followed-up at regular intervals 
with computed tomography scan for years after surgery. 
In view of your patient who ruptured 2.5 years after 
surgery--in fact, I think this was a patient who did not 
have an early endoleak--will all patients need to be fol- 
lowed-up for years with computed tomography scans? At 
what point do you break even on the savings that you have 
from reduced hospitalizations being spent on outpatient 
computed tomography scans? From a medical standpoint, 
do endovascular neurysm repairs actually prevent aortic 
aneurysm rupture? With an l l -month follow-up on aver- 
age and a natural history risk somewhere in the range of 
5% to 8%, we would have expected that I or 2 of your 30 
patients would rupture if unrepaired. You had one rupture 
with an endovascular repair in place. We were told by Dr. 
Parodi about six other patients who ruptured their 
aneurysms after endovascular repair. Do we know yet that 
this technology has a truly beneficial impact on preventing 
aneurysm rupture? If so, where does it stand between the 
natural history curve and the established track record of 
traditional surgical repair? 
Finally, because this technology seems to be here to 
stay, which surgeons will be performing endovascular 
aneurysm repairs 5 or 7 years from now? Right now, this 
appears to be limited to a few highly technical centers that 
are performing a substantial number. When I watch or help 
with these procedures, it seems that endovascular gadgetry 
is incredibly complex and sophisticated. C-arm require- 
ments are mandatory. Will this limit the number of sur- 
geons actually repairing aneurysms? Will the community- 
based surgeon ever perform endovascular neurysm repair? 
Now that we know it is probably here to stay, what does 
your crystal ball tell us about endovascular neurysm repair 
in the year 2002? 
Dr. David C. Brewster. You have obviously raised 
some timely and thorny issues that I will not be able to 
answer entirely. 
In regard to the problems related to kinking of endo- 
graft limbs, this was indeed frustrating. The endografts hat 
we were using were mostly EndoVascular Technologies 
endografts, which are unsupported. It is increasingly clear 
to most investigators that future devices should have a full 
endoskeleton or stent framework support of the entire 
endoluminal conduit to minimize such kinking issues. I 
think that will be an important echnologic advance. 
Because we are only in the early developmental phases of 
such rapidly evolving endoluminal therapy, we are sure to 
see other technologic advances that will certainly reduce 
complexity of the procedures, decrease local vascular com- 
plications, and lead to even better outcome results. Many 
of your other questions relate to the need for further long- 
term follow-up to confirm durability. Obviously, we do not 
have this information yet. 
The femorofemoral component of a treatment strate- 
gy employing aortouniiliac grafts and contralateral iliac 
occlusion might be considered a "weak link". However, 
femorofemoral grafts have generally had good long-term 
durability, especially in patients without significant occlu- 
sive disease. Thus, I think such procedures remain useful, 
especially in elderly high-risk patients with difficult iliac 
artery anatomy or extensive aneurysmal disease. This 
method of treatment will certainly extend ability to treat a 
greater number of patients with aneurysms by means of 
endoluminal techniques. 
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As I tried to emphasize in my report, endoleaks remain 
a significant concern. The EndoVascular Technologies trial, 
which now has follow-up for up to 3 years in some patients, 
frequently observes these problems, and their natural his- 
tory has been rather benign. However, other investigators 
are beginning to realize that some endoleaks, particularly 
those at an attachment site, perhaps have a much more 
ominous implication. I think that it is best to restudy and 
perhaps reintervene atan earfier interval on such patients. 
In addition, it is important to emphasize that reinterven- 
tion does not necessarily have to be surgical intervention. 
In many instances, further endoluminal treatments-- 
balloon dilatation of the stent attachments, deployment of
additional segmental endograft, and so forth--can often 
take care of these problems. 
The endoluminal coiling that we have done within the 
aneurysm sac is designed to promote thrombosis. Thisis a 
method that is used in many other instances by our inter- 
ventional radiology colleagues. We have not proven that it 
enhances thrombosis of the sac, but it seems alogical step 
to help with the problem ofback bleeding from lumbar or 
inferior mesenteric artery b anches into abdominal aortic 
aneurysm sac, which, in our experience, is the source of at 
least one half of the endoleaks. 
Finally, your questions about cost are important. You 
are right that these endografts at the moment are rather 
expensive. This somewhat offsets the savings from intensive 
care traits and hospital stays. We simply do not know yet 
whether this is a cost effective treatment ornot. I think that 
you are right that further analysis in this regard is necessary. 
